Skip to content

Comparison of the Effect of Rifaximin and Probiotic and Bismuth on the Treatment of Susceptible Colon.

Comparison of the effect of three Probiotic Bismuth drugs and Rifaximin in the treatment of Irritable Bowel Syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190524043688N1
Enrollment
120
Registered
2023-12-04
Start date
2020-12-19
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome. Irritable bowel syndrome

Interventions

Intervention 1: The first intervention group: Chemical ingredients : Lactob

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Abdominal pain or any digestive discomfort for at least 3 months and 3 times a month, during one year, these 3 months may be consecutive or non sequential.2. Comes with two of the following three cases: the relief of pain in the development of symptoms of the onset of symptoms, as well as changes in the frequency of atrial fibrillation, the onset of symptoms associated with stool deformity Age 18 to 50 years

Exclusion criteria

Exclusion criteria: 1.History of Celiac Disease 2.Lactase Deficiency 3.Thyroid Diseases 4.Organic intestinal Causes 5.Prohibition of Bismuth Consumption 6.Prohibition of using Rifaximine

Design outcomes

Primary

MeasureTime frame
Stool consistency. Timepoint: Measurement of stool consistency from the beginning of illness and 28 days after the end of the intervention. Method of measurement: Based on the patient's observations and statements (There is no dedicated tool to measure stool consistency).;Flatulence. Timepoint: Measurement of abdominal bloating from the beginning of the illness and 28 days after the end of the intervention. Method of measurement: Based on the patient's observations and statements (There is no specific tool to measure abdominal bloating).;Abdominal Pain. Timepoint: Measurement of abdominal bloating from the beginning of the illness and 28 days after the end of the intervention. Method of measurement: Based on the patient's observations and statements (there is no specific tool to measure abdominal pain).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Seifi

Sanandaj University of Medical Sciences

miladhamdi64@gmail.com+98 87 3371 2229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026